Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation
Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Introduction: The potential of neurofilament light (NfL) as a blood-based biomarker is currently being investigated in autosomal dominant neurodegenerative disease. This study explores the clinical utility of serum-NfL in frontotemporal dementia due to CHMP2B mutation (FTD-3). Methods: This cross-sectional study included serum and CSF data from 38...
Alternative Titles
Full title
Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1159_000513877
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000513877
Other Identifiers
ISSN
1420-8008
E-ISSN
1421-9824
DOI
10.1159/000513877
